Loading…

Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review

Transporters of the solute carrier family 25 (SLC25) regulate the intracellular distribution and concentration of nucleotides, amino acids, dicarboxylates, and vitamins within the mitochondrial and cytoplasmic matrices. This mechanism involves changes in mitochondrial function, regulation of cellula...

Full description

Saved in:
Bibliographic Details
Published in:Cancer control 2024-01, Vol.31, p.10732748241287905
Main Authors: Gao, Renzhuo, Zhou, Dan, Qiu, Xingpeng, Zhang, Jiayi, Luo, Daya, Yang, Xiaohong, Qian, Caiyun, Liu, Zhuoqi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c348t-270bd5f59995fa6e94babf5305e80c12b0be2e0c8472542394098e30e4cda66c3
container_end_page
container_issue
container_start_page 10732748241287905
container_title Cancer control
container_volume 31
creator Gao, Renzhuo
Zhou, Dan
Qiu, Xingpeng
Zhang, Jiayi
Luo, Daya
Yang, Xiaohong
Qian, Caiyun
Liu, Zhuoqi
description Transporters of the solute carrier family 25 (SLC25) regulate the intracellular distribution and concentration of nucleotides, amino acids, dicarboxylates, and vitamins within the mitochondrial and cytoplasmic matrices. This mechanism involves changes in mitochondrial function, regulation of cellular metabolism, and the ability to provide energy. In this review, important members of the SLC25 family and their pathways affecting tumorigenesis and progression are elucidated, highlighting the diversity and complexity of these pathways. Furthermore, the significant potential of the members of SLC25 as both cancer therapeutic targets and biomarkers will be emphasized.
doi_str_mv 10.1177/10732748241287905
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_acf6bd9748024320a1d341f930721b79</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_acf6bd9748024320a1d341f930721b79</doaj_id><sourcerecordid>3108762555</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-270bd5f59995fa6e94babf5305e80c12b0be2e0c8472542394098e30e4cda66c3</originalsourceid><addsrcrecordid>eNplkU1v1DAQhi0Eoh_wA7ggH7ks-DOOuaAqorTSIiooXK2JM9l1lY0XOynqv8dhS0XFyZbfd54Zz0vIK87ecm7MO86MFEbVQnFRG8v0E3LMtahWQmr7tNyLvloMR-Qk5xvGBFNSPSdH0koulRLHBBsYPSZ6vcUEe5yn4OlVnHCcAgwUxo5epbgZY16EHzDMSGNPpy3Sb-tGaPo5TNFv49ilxd9ASqHQzmEXhrv39Ix-xduAv16QZz0MGV_en6fk-_nH6-Zitf7y6bI5W6-8VPVURmVtp3ttrdU9VGhVC22vJdNYM89Fy1oUyHytjNBKSKuYrVEyVL6DqvLylFweuF2EG7dPYQfpzkUI7s9DTBsHqfxkQAe-r9rOluUwoaRgwDupeG8lM4K3xhbWhwNrP7c77HxZSYLhEfSxMoat28Rbx7mSltcL4c09IcWfM-bJ7UL2OAwwYpyzk5zVphJa62LlB6tPMeeE_UMfztyStfsv61Lz-t8BHyr-hit_AzNroy0</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3108762555</pqid></control><display><type>article</type><title>Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review</title><source>Open Access: PubMed Central</source><source>SAGE Open Access</source><source>Publicly Available Content (ProQuest)</source><creator>Gao, Renzhuo ; Zhou, Dan ; Qiu, Xingpeng ; Zhang, Jiayi ; Luo, Daya ; Yang, Xiaohong ; Qian, Caiyun ; Liu, Zhuoqi</creator><creatorcontrib>Gao, Renzhuo ; Zhou, Dan ; Qiu, Xingpeng ; Zhang, Jiayi ; Luo, Daya ; Yang, Xiaohong ; Qian, Caiyun ; Liu, Zhuoqi</creatorcontrib><description>Transporters of the solute carrier family 25 (SLC25) regulate the intracellular distribution and concentration of nucleotides, amino acids, dicarboxylates, and vitamins within the mitochondrial and cytoplasmic matrices. This mechanism involves changes in mitochondrial function, regulation of cellular metabolism, and the ability to provide energy. In this review, important members of the SLC25 family and their pathways affecting tumorigenesis and progression are elucidated, highlighting the diversity and complexity of these pathways. Furthermore, the significant potential of the members of SLC25 as both cancer therapeutic targets and biomarkers will be emphasized.</description><identifier>ISSN: 1073-2748</identifier><identifier>ISSN: 1526-2359</identifier><identifier>EISSN: 1526-2359</identifier><identifier>DOI: 10.1177/10732748241287905</identifier><identifier>PMID: 39313442</identifier><language>eng</language><publisher>United States: SAGE Publications</publisher><subject>Biomarkers, Tumor - metabolism ; Humans ; Mitochondria - metabolism ; Mitochondrial Membrane Transport Proteins - metabolism ; Mitochondrial Proteins ; Neoplasms - metabolism ; Neoplasms - therapy ; Organic Anion Transporters ; Prognosis ; Review</subject><ispartof>Cancer control, 2024-01, Vol.31, p.10732748241287905</ispartof><rights>The Author(s) 2024 2024 SAGE Publications Inc, unless otherwise noted. Manuscript content on this site is licensed under Creative Common Licences</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c348t-270bd5f59995fa6e94babf5305e80c12b0be2e0c8472542394098e30e4cda66c3</cites><orcidid>0000-0001-6985-3173 ; 0009-0007-3936-0096 ; 0000-0003-1227-2436 ; 0009-0007-4415-5409 ; 0009-0006-3698-2036 ; 0009-0004-8210-5646 ; 0000-0002-7293-0886</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439189/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439189/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,37013,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39313442$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gao, Renzhuo</creatorcontrib><creatorcontrib>Zhou, Dan</creatorcontrib><creatorcontrib>Qiu, Xingpeng</creatorcontrib><creatorcontrib>Zhang, Jiayi</creatorcontrib><creatorcontrib>Luo, Daya</creatorcontrib><creatorcontrib>Yang, Xiaohong</creatorcontrib><creatorcontrib>Qian, Caiyun</creatorcontrib><creatorcontrib>Liu, Zhuoqi</creatorcontrib><title>Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review</title><title>Cancer control</title><addtitle>Cancer Control</addtitle><description>Transporters of the solute carrier family 25 (SLC25) regulate the intracellular distribution and concentration of nucleotides, amino acids, dicarboxylates, and vitamins within the mitochondrial and cytoplasmic matrices. This mechanism involves changes in mitochondrial function, regulation of cellular metabolism, and the ability to provide energy. In this review, important members of the SLC25 family and their pathways affecting tumorigenesis and progression are elucidated, highlighting the diversity and complexity of these pathways. Furthermore, the significant potential of the members of SLC25 as both cancer therapeutic targets and biomarkers will be emphasized.</description><subject>Biomarkers, Tumor - metabolism</subject><subject>Humans</subject><subject>Mitochondria - metabolism</subject><subject>Mitochondrial Membrane Transport Proteins - metabolism</subject><subject>Mitochondrial Proteins</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - therapy</subject><subject>Organic Anion Transporters</subject><subject>Prognosis</subject><subject>Review</subject><issn>1073-2748</issn><issn>1526-2359</issn><issn>1526-2359</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNplkU1v1DAQhi0Eoh_wA7ggH7ks-DOOuaAqorTSIiooXK2JM9l1lY0XOynqv8dhS0XFyZbfd54Zz0vIK87ecm7MO86MFEbVQnFRG8v0E3LMtahWQmr7tNyLvloMR-Qk5xvGBFNSPSdH0koulRLHBBsYPSZ6vcUEe5yn4OlVnHCcAgwUxo5epbgZY16EHzDMSGNPpy3Sb-tGaPo5TNFv49ilxd9ASqHQzmEXhrv39Ix-xduAv16QZz0MGV_en6fk-_nH6-Zitf7y6bI5W6-8VPVURmVtp3ttrdU9VGhVC22vJdNYM89Fy1oUyHytjNBKSKuYrVEyVL6DqvLylFweuF2EG7dPYQfpzkUI7s9DTBsHqfxkQAe-r9rOluUwoaRgwDupeG8lM4K3xhbWhwNrP7c77HxZSYLhEfSxMoat28Rbx7mSltcL4c09IcWfM-bJ7UL2OAwwYpyzk5zVphJa62LlB6tPMeeE_UMfztyStfsv61Lz-t8BHyr-hit_AzNroy0</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Gao, Renzhuo</creator><creator>Zhou, Dan</creator><creator>Qiu, Xingpeng</creator><creator>Zhang, Jiayi</creator><creator>Luo, Daya</creator><creator>Yang, Xiaohong</creator><creator>Qian, Caiyun</creator><creator>Liu, Zhuoqi</creator><general>SAGE Publications</general><general>SAGE Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-6985-3173</orcidid><orcidid>https://orcid.org/0009-0007-3936-0096</orcidid><orcidid>https://orcid.org/0000-0003-1227-2436</orcidid><orcidid>https://orcid.org/0009-0007-4415-5409</orcidid><orcidid>https://orcid.org/0009-0006-3698-2036</orcidid><orcidid>https://orcid.org/0009-0004-8210-5646</orcidid><orcidid>https://orcid.org/0000-0002-7293-0886</orcidid></search><sort><creationdate>202401</creationdate><title>Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review</title><author>Gao, Renzhuo ; Zhou, Dan ; Qiu, Xingpeng ; Zhang, Jiayi ; Luo, Daya ; Yang, Xiaohong ; Qian, Caiyun ; Liu, Zhuoqi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-270bd5f59995fa6e94babf5305e80c12b0be2e0c8472542394098e30e4cda66c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomarkers, Tumor - metabolism</topic><topic>Humans</topic><topic>Mitochondria - metabolism</topic><topic>Mitochondrial Membrane Transport Proteins - metabolism</topic><topic>Mitochondrial Proteins</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - therapy</topic><topic>Organic Anion Transporters</topic><topic>Prognosis</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gao, Renzhuo</creatorcontrib><creatorcontrib>Zhou, Dan</creatorcontrib><creatorcontrib>Qiu, Xingpeng</creatorcontrib><creatorcontrib>Zhang, Jiayi</creatorcontrib><creatorcontrib>Luo, Daya</creatorcontrib><creatorcontrib>Yang, Xiaohong</creatorcontrib><creatorcontrib>Qian, Caiyun</creatorcontrib><creatorcontrib>Liu, Zhuoqi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Cancer control</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gao, Renzhuo</au><au>Zhou, Dan</au><au>Qiu, Xingpeng</au><au>Zhang, Jiayi</au><au>Luo, Daya</au><au>Yang, Xiaohong</au><au>Qian, Caiyun</au><au>Liu, Zhuoqi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review</atitle><jtitle>Cancer control</jtitle><addtitle>Cancer Control</addtitle><date>2024-01</date><risdate>2024</risdate><volume>31</volume><spage>10732748241287905</spage><pages>10732748241287905-</pages><issn>1073-2748</issn><issn>1526-2359</issn><eissn>1526-2359</eissn><abstract>Transporters of the solute carrier family 25 (SLC25) regulate the intracellular distribution and concentration of nucleotides, amino acids, dicarboxylates, and vitamins within the mitochondrial and cytoplasmic matrices. This mechanism involves changes in mitochondrial function, regulation of cellular metabolism, and the ability to provide energy. In this review, important members of the SLC25 family and their pathways affecting tumorigenesis and progression are elucidated, highlighting the diversity and complexity of these pathways. Furthermore, the significant potential of the members of SLC25 as both cancer therapeutic targets and biomarkers will be emphasized.</abstract><cop>United States</cop><pub>SAGE Publications</pub><pmid>39313442</pmid><doi>10.1177/10732748241287905</doi><orcidid>https://orcid.org/0000-0001-6985-3173</orcidid><orcidid>https://orcid.org/0009-0007-3936-0096</orcidid><orcidid>https://orcid.org/0000-0003-1227-2436</orcidid><orcidid>https://orcid.org/0009-0007-4415-5409</orcidid><orcidid>https://orcid.org/0009-0006-3698-2036</orcidid><orcidid>https://orcid.org/0009-0004-8210-5646</orcidid><orcidid>https://orcid.org/0000-0002-7293-0886</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1073-2748
ispartof Cancer control, 2024-01, Vol.31, p.10732748241287905
issn 1073-2748
1526-2359
1526-2359
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_acf6bd9748024320a1d341f930721b79
source Open Access: PubMed Central; SAGE Open Access; Publicly Available Content (ProQuest)
subjects Biomarkers, Tumor - metabolism
Humans
Mitochondria - metabolism
Mitochondrial Membrane Transport Proteins - metabolism
Mitochondrial Proteins
Neoplasms - metabolism
Neoplasms - therapy
Organic Anion Transporters
Prognosis
Review
title Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T04%3A30%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cancer%20Therapeutic%20Potential%20and%20Prognostic%20Value%20of%20the%20SLC25%20Mitochondrial%20Carrier%20Family:%20A%20Review&rft.jtitle=Cancer%20control&rft.au=Gao,%20Renzhuo&rft.date=2024-01&rft.volume=31&rft.spage=10732748241287905&rft.pages=10732748241287905-&rft.issn=1073-2748&rft.eissn=1526-2359&rft_id=info:doi/10.1177/10732748241287905&rft_dat=%3Cproquest_doaj_%3E3108762555%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c348t-270bd5f59995fa6e94babf5305e80c12b0be2e0c8472542394098e30e4cda66c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3108762555&rft_id=info:pmid/39313442&rfr_iscdi=true